| human | Q5 |
| P496 | ORCID iD | 0000-0002-0211-0110 |
| P1153 | Scopus author ID | 7003568094 |
| P69 | educated at | McGill University Faculty of Medicine and Health Sciences | Q6801306 |
| P108 | employer | Digital Infuzion (United States) | Q100955871 |
| P734 | family name | Bour | Q16860295 |
| Bour | Q16860295 | ||
| Bour | Q16860295 | ||
| P735 | given name | ??? | Q15727905 |
| ??? | Q15727905 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q52536989 | Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. |
| Q40657919 | Cell surface down-modulation of CD4 after infection by HIV-1. |
| Q40484616 | Clinical correlates and molecular basis of HIV drug resistance |
| Q40579791 | Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression |
| Q21284220 | DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis |
| Q36690766 | Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1 |
| Q34033122 | HIV accessory proteins: multifunctional components of a complex system. |
| Q36803985 | High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells. |
| Q40567149 | Human immunodeficiency virus type 1-associated CD4 downmodulation. |
| Q39485425 | Infection of human monocyte-derived macrophages by human immunodeficiency virus mediated by cell-to-cell transmission. |
| Q36827782 | Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. |
| Q33639849 | Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity. |
| Q33961555 | Molecular interactions of HIV with host factors. |
| Q28257691 | Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel |
| Q44426365 | Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release. |
| Q33640055 | Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. |
| Q35206874 | The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release. |
| Q35854386 | The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? |
| Q35873115 | The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. |
| Q36669879 | The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. |
| Q40816820 | The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. |
| Q24676509 | The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation |
| Q40569844 | The role of CD4 and its downmodulation in establishment and maintenance of HIV-1 infection. |
| Q35854362 | The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. |
| Q34391721 | Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production |
| Q54264083 | [Antiviral strategies in the replication of human immunodeficiency virus] |
| Q37319667 | dCAS: a desktop application for cDNA sequence annotation. |
Search more.